Clinical Trial Update: An Evaluation of the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate in Hemodialysis Patients [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate in patients undergoing hemodialysis; the trial status is complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blood Coagulation Disorders

Drugs mentioned

• Dabigatran etexilate (Dabigatran etexilate)

Snippet

Sponsor: Nova Scotia Health Authority | Conditions: Blood Coagulation Disorders | Phase 1 | Status: COMPLETED